블로그

• [U.S. FDA] FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Adv For Immediate Release August 06, 2026 The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg blog.naver.com · 2026.08.07